Your account is not claimed yet. You can sign up with ORCID to claim your account.

Scott Chih-Hsi Kuo (Chih-Hsi S Kuo, Chih-Hsi Scott Kuo)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Thoracic cancer

Cancers

Therapeutic advances in medical oncology

Vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Rotow, Jyoti D Patel, Matthew P Hanley, Helena Alexandra Yu, Mark M Awad, Jonathan Wade Goldman, Hovav Nechushtan, Matthias Scheffler, Scott Chih-Hsi Kuo, Senthil Rajappa, Guilherme Harada, Sarah Clifford, Alison D Santucci, Laura Silva, Rebecca Tupper, Geoffrey R Oxnard, Jennifer Kherani, Alexander E Drilon
Osimertinib and selpercatinib efficacy, safety, and resistance in a multicenter, prospectively treated cohort of EGFR-mutant and RET fusion-positive lung cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Suey-Haur Lee, Yu-Ching Lin, Li-Chung Chiu, Jia-Shiuan Ju, Pi-Hung Tung, Allen Chung-Cheng Huang, Shih-Hong Li, Yueh-Fu Fang, Chih-Hung Chen, Scott Chih-Hsi Kuo, Chin-Chou Wang, Cheng-Ta Yang, Ping-Chih Hsu
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study. Therapeutic advances in medical oncology 14 (2022)
Scott Chih-Hsi Kuo, Tzu-Hsuan Chiu, Pi-Hung Tung, Chi-Hsien Huang, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Chin-Chou Wang, Ho-Wen Ko, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Cheng-Ta Yang
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation. Cancers 14 (2) (2022)
How-Wen Ko, Chi-Tsun Chiu, Chih-Liang Wang, Tsung-Ying Yang, Chien-Ying Liu, Chih-Teng Yu, Li-Chuan Tseng, Scott Chih-Hsi Kuo, Chin-Chou Wang, Muh-Hwa Yang, Cheng-Ta Yang
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab. Cancers 14 (14) (2022)
Li-Chung Chiu, Ping-Chih Hsu, Tzung-Hai Yen, Scott Chih-Hsi Kuo, Yueh-Fu Fang, Yu-Lun Lo, Shu-Min Lin, Cheng-Ta Yang, Chung-Shu Lee
Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease. Medicina (Kaunas, Lithuania) 57 (11) (2021)
Li-Chung Chiu, Shu-Min Lin, Yu-Lun Lo, Scott Chih-Hsi Kuo, Cheng-Ta Yang, Ping-Chih Hsu
Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC). Vaccines 9 (7) (2021)
Allen Chung-Cheng Huang, Chi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Pi-Hung Tung, Chin-Chou Wang, Chien-Ying Liu, Fu-Tsai Chung, Yueh-Fu Fang, Yi-Ke Guo, Scott Chih-Hsi Kuo, Cheng-Ta Yang
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer. Therapeutic advances in medical oncology 13 (2021)
Chi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, Pi-Hung Tung, Chin-Chou Wang, Chien-Ying Liu, Fu-Tsai Chung, Yueh-Fu Fang, Yi-Ke Guo, Scott Chih-Hsi Kuo, Cheng-Ta Yang
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation. International journal of cancer (2021)
Chia-Hsun Chu, Tzu-Hsuan Chiu, Chin-Chou Wang, Wen-Chen Chang, Allen Chung-Cheng Huang, Chien-Ying Liu, Chih-Liang Wang, Ho-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yi-Ke Guo, Scott Chih-Hsi Kuo, Cheng-Ta Yang
Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer. Thoracic cancer 11 (6) (2020)
Scott Chih-Hsi Kuo, Chi-Hsien Huang, Chien-Ying Liu, Stelios Pavlidis, Ho-Wen Ko, Fu-Tsai Chung, Tin-Yu Lin, Chih-Liang Wang, Yi-Ke Guo, Cheng-Ta Yang
Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib. Targeted oncology 14 (4) (2020)
Scott Chih-Hsi Kuo, Chin-Chou Wang, Yu-Chen Huang, Stelios Pavlidis, Chien-Ying Liu, How-Wen Ko, Fu-Tsai Chung, Tin-Yu Lin, Chih-Liang Wang, Yi-Ke Guo, Cheng-Ta Yang
Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer. Thoracic cancer 10 (5) (2019)
Ping-Chih Hsu, John Wen-Chang Chang, Chun-Chieh Wang, Chen-Te Wu, Yu-Ching Lin, Chih-Liang Wang, Tin-Yu Lin, Shih-Hong Li, Yi-Chen Wu, Scott Chih-Hsi Kuo, Cheng-Ta Yang, Chien-Ying Liu, Chih-Hung Chen
Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non-small cell lung cancer: Results of a single-arm prospective cohort study. Thoracic cancer 10 (8) (2019)
Shih-Hao Huang, Allen Chung-Cheng Huang, Chin-Chou Wang, Wen-Chen Chang, Chien-Ying Liu, Stelios Pavlidis, Ho-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yi-Ke Guo, Scott Chih-Hsi Kuo, Cheng-Ta Yang
Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control. Thoracic cancer 10 (12) (2019)
Yu-Chen Huang, Shih-Min Shen, Chien-Ying Liu, Stelios Pavlidis, Chih-Liang Wang, How-Wen Ko, Fu-Tsai Chung, Tin-Yu Lin, Po-Hao Feng, Kang-Yun Lee, Yi-Ke Guo, Cheng-Ta Yang, Scott Chih-Hsi Kuo
Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR-mutant and EGFR-wild type nonsquamous non-small cell lung cancer. Thoracic cancer 9 (12) (2018)

Scott Chih-Hsi Kuo.css-eqlu8i{font-size:small;padding-left:4px;} (Chih-Hsi S Kuo, Chih-Hsi Scott Kuo)

Publication Activity (10 Years)

Top Topics

Top Venues

Scott Chih-Hsi Kuo (Chih-Hsi S Kuo, Chih-Hsi Scott Kuo)